tiprankstipranks
Arch Biopartners (TSE:ARCH)
TSXV:ARCH
Canadian Market

Arch Biopartners (ARCH) Financial Statements

17 Followers

Arch Biopartners Financial Overview

Arch Biopartners's market cap is currently ―. The company's EPS TTM is C$-0.031; its P/E ratio is -55.91; Arch Biopartners is scheduled to report earnings on May 28, 2024, and the estimated EPS forecast is C$-0.02. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Sep 23Jun 23Mar 23Dec 22
Income Statement-
Total RevenueC$ 298.14KC$ -1.10MC$ 116.37KC$ 2.53MC$ 0.00
Gross ProfitC$ 298.14KC$ -1.10MC$ 116.37KC$ 2.53M-
EBITC$ -694.55KC$ 359.92KC$ -347.66KC$ -890.22KC$ -2.09M
EBITDAC$ -694.55KC$ 359.92KC$ -347.66KC$ -890.22KC$ -2.09M
Net Income Common StockholdersC$ -783.25KC$ 244.28KC$ -450.78KC$ -962.42KC$ -2.16M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 302.63KC$ 831.27KC$ 1.40MC$ 708.49KC$ 159.82K
Total AssetsC$ 636.48KC$ 1.17MC$ 1.42MC$ 3.69MC$ 718.12K
Total DebtC$ 5.04MC$ 4.81MC$ 4.77MC$ 5.71MC$ 4.39M
Net DebtC$ 4.73MC$ 3.98MC$ 3.37MC$ 5.00MC$ 4.23M
Total LiabilitiesC$ 6.35MC$ 6.68MC$ 7.17MC$ 9.12MC$ 5.19M
Stockholders EquityC$ -5.71MC$ -5.51MC$ -5.75MC$ -5.43MC$ -4.47M
Cash Flow-
Free Cash FlowC$ -546.34KC$ 443.13KC$ 567.65KC$ -948.33KC$ -296.53K
Operating Cash FlowC$ -546.34KC$ 443.13KC$ 567.65KC$ -948.33K-
Investing Cash Flow-C$ 1.35MC$ -1.35M--
Financing Cash FlowC$ 17.70KC$ -1.01MC$ 121.00KC$ 1.50MC$ -50.00K
Currency in CAD

Arch Biopartners Earnings and Revenue History

Arch Biopartners Debt to Assets

Arch Biopartners Cash Flow

Arch Biopartners Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis